The 13th Annual Meeting of the Asian Organization for Crohn’s and Colitis（AOCC2025）

*Jiajia Li¹, Ying Xu², Mingyuan Wang¹, Hongjie Zhang¹ (1. The First Affiliated Hospital With Nanjing Medical University, 2. Nanjing First Hospital)

*AYAKO FUCHIGAMI¹ (1. Nippon Koukan Hospital)

*Wenqing Shan^1,2, Yujing Liang³, Jialong Liu^1,2, Ranran Zhang^1,2, Liping Gao^1,2, Lilan Fan^1,2, Yizhang Li^1,2, Guoqingyuan Li^1,2, Chaoran Yang^1,2, Fuan Wang^1,2, Jing Liu³ (1. Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China., 2. Hubei Provincial Clinical Research Center for Intestinal and Colorectal Diseases, Hubei Key Laboratory of Intestinal and Colorectal Diseases, Wuhan, Hubei 430071, China, 3. College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, Hubei, 430071, China.)

Bingjie Xiang^1,2,3, *Zhaoyuan Xu^1,2,3, Xiang Peng^1,2,3,4, Min Zhang^1,2,3,4, Jun Hu^2,3,4, Min Zhi^1,2,3,4 (1. Department of Gastroenterology, The Sixth Affiliated Hospital of Sun Yat-Sen University, 2. Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital of Sun Yat-Sen University, 3. Guangdong Institute of Gastroenterology, 4. Biomedical Innovation Center, The Sixth Affiliated Hospital of Sun Yat-Sen University)

*Yosuke Kurashima^1,2,3, Zhongwei Zhang¹, Yun-Gi Kim⁴, Nozomu Obana⁵, Shinji Fukuda^5,6, Ryutarou Fukui⁷, Kensuke Miyake⁷, Koji Hase⁸, Hiroshi Ohno⁹, Satoshi Uematsu¹⁰, Peter B Ernst³, Hiroshi Kiyono^1,2,3 (1. Department of Innovative Medicine, Graduate School of Medicine, Institute for Advanced Academic Research/ Research Institute of Disaster Medicine, Chiba University, Chiba, Japan, 2. Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., 3. Division of Comparative Pathology and Medicine, Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine, School of Medicine (cMAV), San Diego, CA, USA., 4. Department of Microbiology, School of Pharmacy, Kitasato University, Tokyo 108-8641, Japan, 5. Transborder Medical Research Center, Institute of Medicine, University of Tsukuba, Ibaraki, Japan, 6. Institute for Advanced Biosciences, Keio University, Yamagata, Japan, 7. Division of Innate Immunity, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., 8. Division of Biochemistry, Department of Pharmaceutical Sciences, Faculty of Pharmacy, and Graduate School of Pharmaceutical Sciences, Keio University, Minato-ku, Tokyo, 105-8512, Japan. , 9. Laboratory for Microbiome Sciences and Intestinal Ecosystem, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., 10. Department of Immunology and Genomics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan)

*Chiao-Hsiung Chuang¹, Po-Hsiang Hu³, Er-Hsiang Yang¹, Chung-Ta Lee², Chien-Chin Chen³, Tsunglin Liu³ (1. Department of Internal Medicine, National Cheng Kung University Hospital, 2. Department of Pathology, National Cheng Kung University Hospital, 3. Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University)

*Keiko Maeda¹, Masanao Nakamura¹, Hiroki Kawashima¹ (1. Nagoya University)

*JIAQI YU¹, Keiko Maeda¹, Hiroki Kawashima¹ (1. Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine)

*bingbing li¹, Xiaowei Liu¹ (1. Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan, China)

*Shurong HU¹, Qiao Yu¹, Xiaoying Wang¹, Dingting Xu¹, Yan Chen¹ (1. Second Affiliated Hospital, School of Medicine, Zhejiang University)

Tianyi Li¹, Dongliang Guo¹, Kang Ding¹, *Yuanyuan Ge¹ (1. Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine)